We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAI
2051
DELISTED
CAI International, Inc.
CAI
$1.6M ﹤0.01%
28,503
-3,063
-10% -$136K
PSN icon
2052
Parsons
PSN
$5.08B
$1.59M ﹤0.01%
40,492
+11,432
+39% +$470K
CLW icon
2053
Clearwater Paper
CLW
$376M
$1.59M ﹤0.01%
54,948
-2,928
-5% -$91.4K
REAL icon
2054
The RealReal
REAL
$1.48B
$1.59M ﹤0.01%
80,359
+9,199
+13% +$188K
SILK
2055
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.59M ﹤0.01%
33,142
+3,378
+11% +$172K
CENT icon
2056
Central Garden & Pet Co
CENT
$2.8B
$1.58M ﹤0.01%
37,421
-1,597
-4% -$71.6K
DCPH
2057
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.58M ﹤0.01%
43,076
-678
-2% -$26.3K
SRCE icon
2058
1st Source
SRCE
$2.12B
$1.58M ﹤0.01%
33,918
-2,371
-7% -$114K
UPST icon
2059
Upstart Holdings
UPST
$3.03B
$1.57M ﹤0.01%
12,604
-1,601
-11% -$197K
PFC
2060
DELISTED
Premier Financial Corp. Common Stock
PFC
$1.57M ﹤0.01%
55,258
-6,575
-11% -$204K
HRTX icon
2061
Heron Therapeutics
HRTX
$92.9M
$1.56M ﹤0.01%
100,829
-4,047
-4% -$64.4K
DNMR
2062
DELISTED
Danimer Scientific, Inc.
DNMR
$1.56M ﹤0.01%
+1,558
New +$1.55M
GPRO icon
2063
GoPro
GPRO
$126M
$1.56M ﹤0.01%
133,832
-17,807
-12% -$201K
LBRT icon
2064
Liberty Energy
LBRT
$3.25B
$1.55M ﹤0.01%
109,339
-2,383
-2% -$32.2K
FWONA icon
2065
Liberty Media Series A
FWONA
$23.5B
$1.55M ﹤0.01%
37,869
+313
+0.8% +$12.1K
AVD icon
2066
American Vanguard Corp
AVD
$68.9M
$1.54M ﹤0.01%
88,229
-4,467
-5% -$84.8K
BLNK icon
2067
Blink Charging
BLNK
$87.9M
$1.54M ﹤0.01%
+37,492
New +$1.39M
OCGN icon
2068
Ocugen
OCGN
$434M
$1.54M ﹤0.01%
+191,485
New +$1.62M
WOOF icon
2069
Petco
WOOF
$794M
$1.53M ﹤0.01%
68,417
+19,865
+41% +$465K
ANAT
2070
DELISTED
American National Group, Inc. Common Stock
ANAT
$1.53M ﹤0.01%
10,320
+1,777
+21% +$238K
REYN icon
2071
Reynolds Consumer Products
REYN
$5.59B
$1.53M ﹤0.01%
50,362
+2,390
+5% +$72.5K
FRO icon
2072
Frontline
FRO
$8.85B
$1.53M ﹤0.01%
169,561
-18,150
-10% -$146K
IDEX
2073
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$1.53M ﹤0.01%
+4,299
New +$1.53M
SYBT icon
2074
Stock Yards Bancorp
SYBT
$2.6B
$1.52M ﹤0.01%
29,817
-3,225
-10% -$167K
COWN
2075
DELISTED
Cowen Inc. Class A Common Stock
COWN
$1.52M ﹤0.01%
36,966
-57
-0.2% -$2.24K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.